ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Scope & Guideline

Advancing the Frontiers of Biochemical and Biophysical Research.

Introduction

Explore the comprehensive scope of ACTA BIOCHIMICA ET BIOPHYSICA SINICA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ACTA BIOCHIMICA ET BIOPHYSICA SINICA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1672-9145
PublisherSCIENCE PRESS
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationACTA BIOCH BIOPH SIN / Acta Biochim. Biophys. Sin.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING 100009, PEOPLES R CHINA

Aims and Scopes

ACTA BIOCHIMICA ET BIOPHYSICA SINICA focuses on the biochemical and biophysical aspects of biological processes, offering insights into molecular mechanisms underlying various diseases and therapeutic approaches.
  1. Glycosylation and its Implications:
    The journal has a strong emphasis on the role of glycosylation in disease mechanisms, particularly in cancer and neurodegenerative diseases. This includes studies on glyco-signatures and post-translational modifications that influence cellular functions.
  2. Cancer Biology and Therapeutics:
    A significant portion of the research is dedicated to understanding cancer biology, including tumor microenvironments, resistance mechanisms, and potential therapeutic targets. The journal publishes studies on cellular signaling pathways involved in cancer progression.
  3. Immunology and Inflammation:
    The journal covers research related to immune responses in various contexts, including cancer immunotherapy, autoimmune diseases, and inflammatory responses. This includes studies on macrophage polarization and the role of immune cells in disease progression.
  4. Metabolism and Disease:
    Research on metabolic pathways and their implications in diseases such as diabetes, obesity, and cardiovascular diseases is prevalent. This includes studies on metabolic reprogramming in cancer and the impact of dietary components on health.
  5. Molecular Mechanisms and Target Identification:
    The journal emphasizes the molecular mechanisms of action for various compounds, including natural products and synthetic drugs, aiming to identify new therapeutic targets for disease management.
Recent publications in ACTA BIOCHIMICA ET BIOPHYSICA SINICA reveal several emerging themes that indicate a shift towards more innovative and relevant areas of research.
  1. Glycosylation as a Therapeutic Target:
    Research on glycosylation has surged, particularly in its role in cancer and immune responses. This includes studies that explore glycosylation patterns as potential biomarkers and therapeutic targets, highlighting its significance in personalized medicine.
  2. Metabolic Reprogramming in Cancer:
    There is a growing focus on the intersection of metabolism and cancer biology, with studies exploring how metabolic changes drive tumorigenesis and treatment resistance. This area is increasingly relevant as researchers seek to understand cancer metabolism for therapeutic interventions.
  3. Cellular Mechanotransduction:
    Emerging studies are focusing on how mechanical forces influence cellular behavior, particularly in cancer and tissue regeneration. This theme reflects an interdisciplinary approach combining biology, physics, and engineering to understand cellular responses.
  4. Role of Non-Coding RNAs:
    Research on non-coding RNAs, particularly in the context of cancer and metabolic diseases, is gaining momentum. These studies are exploring their roles in gene regulation and potential as therapeutic targets.
  5. Immunotherapy and Immune Modulation:
    There is a significant increase in research related to immunotherapy, particularly in relation to cancer treatment. This includes studies on immune checkpoint inhibitors, CAR-T cell therapies, and the modulation of immune responses to enhance therapeutic efficacy.

Declining or Waning

While ACTA BIOCHIMICA ET BIOPHYSICA SINICA maintains a broad focus, certain themes have shown a decline in prominence in recent publications, reflecting shifts in research interests.
  1. Traditional Medicinal Approaches:
    There has been a noticeable decrease in studies exclusively focused on traditional Chinese medicine compared to previous years. This may suggest a shift towards more modern, mechanistic studies that integrate traditional knowledge with contemporary scientific methods.
  2. Basic Biochemical Techniques:
    Research that primarily focuses on basic biochemical techniques without application to specific diseases or therapeutic contexts appears to be waning. There is a trend towards more applied research that connects biochemical findings with clinical relevance.
  3. Animal Models in Basic Research:
    The use of animal models for purely basic research has seen a decline, likely due to increasing emphasis on translational research and the need for more human-relevant models that can better predict clinical outcomes.

Similar Journals

Frontiers in Bioscience-Landmark

Uncovering Landmark Research in Life Sciences
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Illuminating the Path of Biochemical Exploration
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Connecting researchers through groundbreaking discoveries.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Showcasing Breakthroughs in Cellular Physiology
Publisher: Cell Physiol Biochem Press GmbH & CoISSN: 1015-8987Frequency: 6 issues/year

Cellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.

International Journal of Biological Sciences

Advancing the Frontiers of Life Sciences
Publisher: IVYSPRING INT PUBLISSN: 1449-2288Frequency: 10 issues/year

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.

BIOSCIENCE REPORTS

Connecting Researchers with Groundbreaking Findings
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

Cell Communication and Signaling

Illuminating the Pathways of Cellular Dialogue
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

CELLULAR SIGNALLING

Connecting Discoveries in Molecular Biology
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

Biochemistry and Biophysics Reports

Unlocking the mysteries of biochemistry and biophysics.
Publisher: ELSEVIERISSN: 2405-5808Frequency: 4 issues/year

Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.

Annual Review of Biochemistry

Connecting Past Discoveries with Future Innovations
Publisher: ANNUAL REVIEWSISSN: 0066-4154Frequency: 1 issue/year

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.